Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease

Detalles Bibliográficos
Autores principales: Nuvoli, Barbara, Germoni, Sabrina, Morosetti, Carlotta, Santoro, Raffaela, Cortese, Giancarlo, Masi, Serena, Cordone, Iole, Galati, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733132/
https://www.ncbi.nlm.nih.gov/pubmed/36482446
http://dx.doi.org/10.1186/s12943-022-01692-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733132/
https://www.ncbi.nlm.nih.gov/pubmed/36482446
http://dx.doi.org/10.1186/s12943-022-01692-9

Ejemplares similares